Search Results
Geoff Kerchner, MD, PhD: Gantenerumab as Disease-Modifying Treatment in Early Alzheimer Disease
Alzheimer’s Disease The Latest Updates on Diagnosis and Treatment Geoffrey Kerchner, MD, PhD
Assaulting Alzheimer's Disease | Geoffrey A. Kerchner | Talks at Google
Updates in pharmacological treatment of Alzheimer’s disease: lecanemab, donanemab and gantenerumab
Advances in Alzheimer's disease biomarkers & therapies
Important developments in dementia: biomarkers & clinical trials
Second generation of anti-amyloid monoclonal antibodies for Alzheimer's disease
2016 Updates on Dementia: Update on experimental therapeutic approaches
Gantenerumab data presented at CTAD- ADDF statement
Research Grand Rounds: Alzheimer's Disease Spectrum Trials - Where Are We Now?
Question and Answer Discussion Geoffrey Kerchner and Ruth Gay
A drug for Alzheimer/dementia (Aducanumab) was endorsed?! Reaction of a neuroscientist & life update
